Skip to content
Japan
-
Olympus expands its innovation commitment with USD150M Venture Capital Fund II
These investments will focus primarily on companies developing breakthrough technologies in gastrointestinal (GI), urology, and respiratory care.
-
Takeda-Innovent closes USD11.4B immuno-oncology partnership
The two pharmaceutical giants originally signed the agreement in October 2025, establishing a framework centered on bispecific antibodies and ADCs.